Last filing: Jun 15, 2026.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| BeOne Medicines Ltd. (ONC) | Director | Mar 6, 2020 | Jun 15, 2026 |
| Amgen (AMGN) | Former EVP, Global Commercial Ops. | Oct 28, 2011 | May 7, 2018 |
| Bristol Myers Squibb (BMY) | Former SVP ComOps Pres USJap Int | Jun 1, 2007 | May 17, 2011 |
Recent filings
The last day with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jun 11, 2026, BeOne Medicines Ltd.: 18,980 shares awarded. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.